image
REGENXBIO Inc. RGNX
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 9.63
-13.6 %
$ 477 M
Market Cap
-1.92
P/E
INCOME STATEMENT
90.2 M REVENUE
-19.94%
Growth Rates
1Year -19.94%
3Years -16.42%
5Years -16.21%
7Years 53.04%
10Years 30.95%
-268 M OPERATING INCOME
-2.00%
Growth Rates
1Year -2.00%
3Years -31.01%
5Years -32.24%
7Years -22.35%
10Years -49.60%
-263 M NET INCOME
6.00%
Growth Rates
1Year 6.00%
3Years -33.30%
5Years -29.46%
7Years -22.69%
10Years -47.55%
EFFICIENCY
Earnings Waterfall REGENXBIO Inc.
image
Revenue 90.2 M
Cost Of Revenue 37.2 M
Gross Profit 53 M
Operating Expenses 321 M
Operating Income -268 M
Other Expenses -4.63 M
Net Income -263 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013
REVENUE
Revenue 90.2 112.7 470.3 154.6 35.2 218.5 10.4 4.6 7.6 6.1 6.1
GROSS PROFIT
Cost Of Revenue 37.2 54.5 51.8 35.7 8.2 9.6 1.7 1.0 1.5 1.0 0.3
Gross Profit 53.0 58.2 418.5 118.9 27.0 208.9 8.7 3.6 6.1 5.1 5.8
OPERATING INCOME
Operating Expenses 321.2 321.1 258.5 238.1 176.0 120.8 84.6 69.0 29.2 8.8 10.5
Selling, General and Administrative Expenses 88.5 85.3 79.3 63.8 51.8 36.9 27.2 23.6 11.9 3.9 5.5
Research and Development Expenses 232.3 242.5 181.4 166.3 124.2 83.9 57.2 45.5 17.3 5.0 5.1
Operating Income (268.1) (262.9) 160.0 (119.2) (149.0) 88.1 (75.9) (65.3) (23.1) (3.7) (4.8)
PRE-TAX INCOME
Interest Income Expense 6.9 23.3 26.3 0.8 0 0 0 0 20 K 0.3 0.6
Total Other Income 4.5 (17.5) (18.7) 13.2 51.5 16.0 2.7 1.9 0.3 (0.3) (0.6)
Pre-Tax Income (263.6) (280.4) 141.2 (106.0) (97.5) 104.1 (73.2) (63.4) (22.8) (4.0) (5.4)
NET INCOME
Tax Provision (0.2) 84 K 13.4 5.2 (2.8) 4.2 0.7 (0.4) 60 K 0.3 0.6
Net Income (263.5) (280.3) 127.8 (111.2) (94.7) 99.9 (73.2) (63.0) (22.8) (4.0) (5.4)
EPS 6.02 6.5 3.01 2.98 2.58 2.73 2.45 2.38 2.49 0.3 0.41